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ABSTRACT
Toxicity of phytochemicals, plant-based extracts and dietary supplements, and medicinal plants in general, is of medical importance 
and must be considered in phytotherapy and other plant uses. We show in this report how general database analyses can provide 
a quantitative assessment of research and evidence related to toxicity of medicinal plants or specific phytochemicals. As examples, 
several medicinal plants are analyzed for their relation to nephrotoxicity and hepatotoxicity. The results of analyses in different data-
bases are similar, and reveal the two best-established toxic effects among the group of plants that were examined: nephrotoxicity of 
Aristolochia fangchi and hepatotoxicity of Larrea tridentata.
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therapeutic associations, e.g., Momordica and potential 
applications to diabetes (Chatterjee, 1963; Leatherdale et 
al., 1981; Yadav et al., 2005; Jung et al., 2006). Aristolochia 
and Larrea were selected because of their known toxicities. 
Aristolochia and its constituent aristolochic acids have 
reported nephrotoxicity, and their use may increase the 
risk urothelial carcinomas (Debelle et al., 2002; Debelle 
et al., 2002; Ioset et al., 2003; Martinez et al., 2002; 
Yuan et al., 2009). For Larrea and one of its polyphenol 
components, nordihydroguaiaretic acid, hepatotoxicity 
and pro-oxidative activity have been reported (Gay and 
Musser, 2008; Sahu et al., 2006). These plants could, thus, 
represent internal controls for the exemplary analyses 
reported in this work and for future analyses of other 
plants, toxicity parameters, or databases. Some plants 
commonly used in phytotherapy ( cf. Ness, 1999) with 
a wide range of reported therapeutic effects were also 
included for comparison, e.g., Echinacea and Allium.
Quantitative determinations of toxicity-plant associa-
tions, referred to as an association index (Ai, see Methods 
section below), can be used to compare different databases 
and provide a measure of the best-established phytotoxic 
effects of a given medicinal plant, or identify the plant 
with the most evidence for a particular toxic effect such 
as hepatotoxicity. As an example of the method, two types 
of databases were used. The first database searched was 
Medline (PubMed), a health-specific database: http://www.
Introduction
Phytotoxicity is an important concern in phytomedicine 
and other situations where potentially toxic plants are 
ingested. A clinician or researcher may want to obtain 
a quantitative indication of the best-established or 
most-researched phytotoxic effect of a given medicinal 
plant (cf. Suter et al., 2004; Kiefer et al., 2001). To pro-
vide a large-scale database analyses in such a context, a 
phytomedicinal informatics approach is described. As 
examples, six medicinal plants – Allium sativum (A.s.); 
Echinacea purpurea (E.p.); Mormordica charantia 
(M.c.); Aristolochia fangchi (A.f.); Larrea tridentate (L.t.); 
Zingiber officinalis (Z.o.); Vaccinium myrtillus (V.m.) – 
are analyzed for parameters related to nephrotoxicity 
(Nx) and hepatotoxicity (Hx). 
To better illustrate the method and provide a larger 
base for comparisons, other parameters related to acute 
and chronic medical conditions are also included: nausea 
(Na), diabetes (Db), and inflammation (If). Some of the 
plants were selected because of well-documented specific 
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ncbi.nlm.nih.gov/entrez/query.fcgi?DB=pubmed. The sec-
ond database searched was the internet (world-wide web, 
www; searched with the Google™ search engine http://
www.google.ca/), a general database that is not limited to 
scientific evidence (see Results and Discussion section).
Methods
The first step in the analysis is to determine the number 
of identified database cases (‘hits’) for a given plant (Pl) 
such as ‘Aristolochia fangchi’, and for a given biomedical 
parameter (Bm) such as ‘nephrotoxicity’. The second step 
is to determine the number of identified database cases 
for the combination (Co) of the above two parameters, one 
plant and one biomedical, e.g., number of cases or hits for 
‘Aristolochia fangchi and nephrotoxicity’. The corrected 
association index (Ai) of the two parameters is then deter-
mined by the following calculation: Ai = (Co/Bm) (Co/Pl).
Dividing the Co term by each of its components indi-
vidually (Bm or Pl), as shown in the above equation, pro-
vides an important abundance correction, and allows for 
more accurate Ai estimates when comparing extensively 
researched plants or toxicities with those plants and toxic 
activities that are much less extensively researched.
The largest Ai value for a given plant (e.g., the Ai for 
M.c.-Db in Figure 1) is used to calculate all the relative Ai 
values (rAi) for that same plant with each of the biomedi-
cal terms. For example, the calculation of all the rAi values 
for the plant M.c. was performed using the following five 
equations (the bars that correspond to these values can be 
seen in Figure 1 along the M.c. axis): 
rAiMcDb  = (AiMcDb)/( AiMcDb)   = 1
rAiMcNa  = (AiMcNa)/( AiMcDb)  << 1
rAiMcHx  = (AiMcHx)/( AiMcDb)  << 1
rAiMcNx  = (AiMcNx)/( AiMcDb)  << 1
rAiMcIf   = (AiMcIf)/( AiMcDb)   << 1
Similarly, the largest Ai value for a given biomedical 
parameter (e.g., the Ai for Nx-A.f. in Figure 2) is used to 
calculate all the relative Ai values (rAi) for that same 
biomedical term with each of the plants. For example, the 
calculation of all the rAi values for the Nx (nephrotoxicity) 
term was performed using the following seven equations 
(the bars that correspond to these values can be seen in 
Figure 2 along the Nx axis): 
rAiNxAf  = (AiNxAf)/( AiNxAf)   = 1
rAiNxMc  = (AiNxMc)/( AiNxAf)   << 1
rAiNxAs  = (AiNxAs)/( AiNxAf)   < 1
rAiNxEp  = (AiNxEp)/( AiNxAf)   <<1
rAiNxZo  = (AiNxZo)/( AiNxAf)   <<1
rAiNxLt   = (AiNxLt)/( AiNxAf)   < 1
rAiNxVm  = (AiNxVm)/( AiNxAf)   << 1
An additional calculation is performed to emphasize 
the relative strengths of rAi values by squaring the two 
corresponding values (one based on Figure 1 values, and 
the other on Figure 2 values) to yield the most specific 
association parameter, rAi2. These rAi2 values are graphed 
in Figure 3 and their significance is further discussed in 
the next section. As an example, the rAi2 value for the 
Db-M.c. relation using the values from Figure 1 and 2 
was calculated as follows (result is graphed in Figure 3A): 
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Figure 1. Relative association indices for each plant with the fi  ve 
biomedical terms. A value of 1 indicates the one, strongest bio-
medical association for that particular plant (asterisk). This graph 
is based on Medline PubMed data. The ‘AI’ of the y-axis repre-
sents rAi (see text for its defi  nition).
Figure 2. Relative association indices for each biomedical term 
with the seven plants. A value of 1 indicates the one, strongest 
plant association for that particular biomedical term (asterisk). 
This graph is based on Medline PubMed data. The ‘AI’ of the y-axis 
represents rAi (see text for its defi  nition).84
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rAi2 = (rAiMcDb) (rAiDbMc) = (1) (1) = 1. As an additional 
example, the rAi2 value for the Nx-A.s. relation using 
the values from Figure 1 and 2 was calculated as follows 
(result is graphed in Figure 3A): rAi2 = (rAiAsNx) (rAiNxAs) 
= (1) (0.2) = 0.2
Results and discussion
In terms of the biomedical-specific database (Medline), 
Figure 1 shows the relative relation (relative associa-
tion index, rAi) of each of the seven plants with all five 
biomedical parameters; whereas Figure 2 shows the rAi 
of each of the five biomedical parameters with all seven 
of the plants examined. Thus, for each plant-biomedical 
parameter relation, there are two possible rAi’s, one 
based on the most active plant for a given biomedical 
parameter, and the other based on the most affected bio-
medical parameter for a given plant. This paper proposes 
a novel combination of these two rAi’s to yield a highly 
specific indicator, rAi2, for a given plant-biomedical 
parameter relation. To allow comparisons of data from 
two large databases, we ultimately calculated rAi2 of a 
given plant-biomedical parameter relation for both the 
biomedical-specific database (Medline, Figure 3A) and the 
less-specific global internet database (www, Figure 3B). 
In terms of toxicity, the results indicate that 
Aristolochia (A.f.) exhibits a major relation with neph-
rotoxicity; this was observed both through a selection 
process based on plant activities (Figure 1) and based 
on biomedical parameters (Figure 2). This major rela-
tion is expected based on the evidence that Aristolochia 
phytochemicals are causally involved in such toxicity 
(see Introduction for references). The results do not show 
evidence for Aristolochia hepatotoxicity; but instead, 
the results of Figures 1 and 2 identify and quantify the 
evidence base for the hepatotoxicity of Larrea (L.t.). In 
the more stringent analysis (rAi2) represented by Figure 3, 
Larrea-hepatotoxicity and Aristolochia-nerphrotoxicity 
are the only two major plant-toxicity associations (note a 
lack of Larrea-nephrotoxicity association). The two plant-
toxicity associations are identified in both the Medline 
database (Figure 3A) and the very large, less-specific, www 
(Figure 3B) database. These two databases are compared 
further below.
Two opposite effects can contribute to a toxicity rela-
tion for a given plant, one as a cause of the toxicity and 
the other as a protective (or anti-toxic) effect. Allium has 
a strong relation with four of the biomedical parameters, 
including Nx and Hx, in terms of rAi (Figure 1); but 
as shown in Figure 3, the strength of the associations 
(especially for Hx and Nx) is diminished with the more 
stringent rAi2. It should be noted in this context that 
there is a large database of reported therapeutic effects 
of Allium for many biomedical parameters including pro-
tection of kidney and liver from toxicity caused by other 
compounds and plants. Similarly, of the five biomedical 
effects analyzed in this study, the major reported activ-
ity for Echinacea (E.p.) is anti-inflammatory (cf. results 
of current study in Figures 1–3), and the major reported 
activity for Zingiber (Z.o.) is anti-nausea (cf. results of 
current study in Figures 1–3).
The data in Figure 3 also verify the diabetes-Momordica 
relation that was included as an additional positive control 
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Figure 3. Product of the relative association indices (rAi’s) for each plant-biomedical term association. Each specifi  c bar 
from Figure 1 was multiplied by its corresponding bar in Figure 2 to yield the highly specifi  c rAi2 value (indicated as ‘AI2’ on 
the y-axes). (A) graph based on Medline PubMed database; (B) graph based on the much larger and less-specifi  c world-
wide-web (www) database.85
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(see Introduction). As a negative control, Vaccinium 
(V.m.) has a wide range of potential effects, and the 
evidence in the databases is not dominated by any one of 
the five biomedical parameters used in the current study; 
Figure 3 shown no major biomedical parameter relations 
for Vaccinium. Moreover, the Allium (anti-)inflammation 
relation that is prominent in the global www database 
(Figure 3B) is not confirmed in Medline (Figure 3A), a 
database with a more stringent selection for scientific evi-
dence in relation to biomedical applications. Medline is 
likely to provide a better estimate of existing evidence for 
toxic or therapeutic effects, and also for biochemical or 
clinical research activity related to the health parameters 
of a given plant or its constituent phytochemicals. The 
internet (www), as a general database, is influence by a 
relatively large number of factors that are less related to 
scientific evidence, e.g., proposed therapeutic applications 
by product vendors or applications based on traditional 
uses. 
The phytomedicinal informatics procedure presented 
in this report is more generally applicable to toxicologi-
cal research. Large databases that include toxicological 
effects of plants, plant extracts, or specific phytochemi-
cals may be searched; and the evidence for an association 
of the plants or compounds to the specific toxicity target 
sites (e.g., organs, tissues, cells) or toxicity processes (e.g., 
cell transport, signaling, gene expression, DNA damage) 
can be quantified. The current study introduces a novel 
rAi2 parameter that incorporates information from large 
databases to identify and quantify relative toxic effects 
(and other effects for comparison) of a group of medicinal 
plants, and relative toxicity of a given medicinal plant. 
The example provided by the study identifies two plants 
with major evidence for hepato- or nephrotoxic effects, 
and quantifies the relative evidence for all of the seven 
plants analyzed. Moreover, because these databases 
are dynamic, it is important to emphasize the need to 
reevaluate the associative parameters such as rAi2 on a 
regular basis to incorporate the results of novel studies. 
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